A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

December 14, 2016

Primary Completion Date

December 11, 2018

Study Completion Date

February 5, 2021

Conditions
Crohn's Disease
Interventions
DRUG

Mirikizumab

DRUG

Placebo

Trial Locations (108)

1036

Obudai Egeszsegugyi Centrum Kft, Budapest

1070

Hospital Universitaire Erasme Brussel, Brussels

2600

Javorszky Odon Hospital, Vác

3065

St Vincents Hospital Melbourne, Fitzroy

3350

Ballarat Health Services - Base Hospital, Ballarat

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

6525

Radboud Universitair Medisch Centrum Nijmegen, Nijmegen

8091

Universitätsspital Zürich, Zurich

9000

Universitair Ziekenhuis Gent, Ghent

10032

Columbia University Medical Center, New York

11021

NYU Langone Long Island Clinical Research Associates, Great Neck

21005

Vinnitsa City Clinical Hospital #1, Vinnytsia

21030

SRI of Invalid Rehabil.,Educ.Scient.Med.Complex, Vinnytsia

21237

MedStar Health Research Institute, Rosedale

27599

University of North Carolina, Chapel Hill

27834

Carolina Digestive Diseases, Greenville

30309

Digestive Healthcare of Georgia, Atlanta

31904

Columbus Regional Research Institute, Columbus

32801

Clinical Neuroscience Solutions Inc, Orlando

33012

Wellness Clinical Research, Hialeah Gardens

33136

University of Miami, Miami

33176

Vista Health Research, Miami

33765

Clinical Research of West Florida, Clearwater

35801

Longwood Research, Huntsville

38138

Gastro One, Germantown

38261

Advanced Gastroenterology, Union City

40113

Krajska zdravotni a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Ústí nad Labem

40206

Robley Rex VAMC, Louisville

42303

Health Quest Medical Care, Owensboro

44106

University Hospitals Health Center, Cleveland

45219

Consultants For Clinical Research, Cincinnati

46202

Indiana University Health, Indianapolis

48109

University of Michigan Health Systems, Ann Arbor

48197

Huron Gastroenterology Associates, Ypsilanti

50012

Hepato-gastroenterologie HK, s.r.o., Hradec Králové

55446

Minnesota Gastroenterology, P.A., Plymouth

63110

Washington University Medical School, St Louis

63128

St. Louis Center for Clinical Research, St Louis

65117

Odesa Regional Clinical Hospital, Odesa

69035

City Clinical Hospital #6, Zaporizhzhia

69104

CI City Hospital #1, Zaporizhzhia

71105

Louisiana Research Center, Shreveport

71201

Delta Research Partners LLC, Monroe

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74135

Healthcare Research Consultant, Tulsa

75082

Digestive Health Associates of Texas, Richardson

76012

Texas Clinical Research Institute, LLC, Arlington

76275

Krajska nemocnice T. Bati a.s., Zlín

77004

Hermann Drive Surgical Hospital, Houston

78229

San Antonio Gastroenterology, San Antonio

79010

Lviv Regional Central Hospital, Lviv

80918

Delta Waves Sleep Disorders and Research Center, Colorado Springs

84124

Care Access Research - Salt Lake City, Salt Lake City

85710

Del Sol Research Management, LLC, Tucson

88018

A. Novak Transcarpathian Regional Clinical Hospital, Uzhhorod

89113

Las Vegas Medical Research, Las Vegas

92843

Valley View Internal Medicine, Garden Grove

93003

Ventura Clinical Trials, Ventura

98101

Virginia Mason Medical Center, Seattle

194356

Baltic Medicine, Saint Petersburg

195257

City Hospital of Saint Martyr Elizabeth, Saint Petersburg

196143

LLC Scientific Research Centre EKO-Bezopasnost, Saint Petersburg

196603

Private Medical Institution Evromedservis, Pushkin

300002

S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timișoara

410469

SC Pelican SRL, Oradea

432063

Ulyanovsk Regional Clinical Hospital, Ulyanovsk

443001

Medical Institute REAVIZ, Samara

443041

NonState Healthcare Institution Central Clinical Hospital, Samara

614068

City Clinical Hospital # 2 n.a. Fedor Khristoforovich Gral, Perm

630091

Novosibirsk State Medical University, Novosibirsk

630117

FSBI Scientific Research Inst. of Physyology and Basic Medic, Novosibirsk

644024

Ultramed, Omsk

06518

Medical Research Center of Connecticut, Hamden

07666

Holy Name Medical Center, Teaneck

02865

Ocean State Clinical Research Partners, Lincoln

98195-6424

University of Washington Medical Center, Seattle

P3C 5K6

Sudbury Endoscopy Centre, Greater Sudbury

779 00

Gregar s.r.o., Olomouc

150 06

Fakultni Nemocnice v Motole, Prague

140 59

Thomayerova Nemocnice, Praha 4 - Krc

285 8471

Toho University School of Medicine, Sakura Hospital, Sakura-shi

802-0077

Kitakyushu Municipal Medical Center, Kitakyusyu-shi

818 8502

Fukuoka University Chikushi Hospital, Chikushino-shi

060 0033

Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo

892-0846

Sameshima Hospital, Kagoshima

247-0056

Gokeikai Ofuna Chuo Hospital, Kamakura-shi

981 3213

Takagi Clinic, Sendai

530-0011

Kinshukai Infusion Clinic, Osaka

113-8519

Tokyo Medical And Dental University Hospital, Bunkyo-ku

181-8611

Kyorin University Hospital, Mitaka

169-0073

JHCO Tokyo Yamate Medical Center, Shinjuku-ku

930-8550

Toyama Prefectural Central Hospital, Toyama

814-0180

Fukuoka University Hospital, Fukuoka

5022 GC

St Elisabeth Ziekenhuis, Tilburg

1105 AZ

Academisch Medisch Centrum, Amsterdam

3015 CE

Erasmus Medisch Centrum, Rotterdam

85-168

Szpital Uniwersytecki nr 2 im. dr J. Biziela, Bydgoszcz

20-362

KO-MED Centra Kliniczne Lublin II, Lublin

60-529

SOLUMED Centrum Medyczne, Poznan

35-302

Korczowski Bartosz, Gabinet Lekarski, Rzeszów

71-434

Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin

00-632

Centrum Zdrowia Matki, Dziecka i Mlodziezy, Warsaw

50-449

Melita Medical Sp. Z O. O., Wroclaw

010719

SC Med Life SA, Bucharest

02091

Kyiv Municipal Clinical Hospital #1, Kyiv

04107

"Communal institution of the Kyiv Regional Council Kyiv Regional Clinical Oncology Dispensary", Kyiv

G51 4TF

Queen Elizabeth University Hospital, Glasgow

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02891226 - A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease | Biotech Hunter | Biotech Hunter